• Skip to main content
❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Radiation Biology ❭ Project groups ❭ Weyergang project group ❭ Tweets ❭
  • Search
  • Publication search
  • Print page

Go to AWeyergang on Twitter

 
Page visits: 401

Home Project groups Weyergang project group

  • Group members
  • Projects
  • Publications
  • Contact
  • Tweets
  • LinkedIn

Recent publications

Weisheit S, Wegner CS, Ailte I, Radulovic M, Weyergang A, Selbo PK, Brech A (2021)
Inhibiting autophagy increases the efficacy of low-dose photodynamic therapy
Biochem Pharmacol, 194, 114837
DOI 10.1016/j.bcp.2021.114837, PubMed 34780750

Engebraaten O, Yau C, Berg K, Borgen E, Garred Ø, Berstad MEB, Fremstedal ASV, DeMichele A, Veer LV', Esserman L, Weyergang A (2021)
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Nat Commun, 12 (1), 6427
DOI 10.1038/s41467-021-26018-z, PubMed 34741021

Berstad MEB, Cheung LH, Weyergang A (2020)
Production of Recombinant Gelonin Using an Automated Liquid Chromatography System
Toxins (Basel), 12 (8)
DOI 10.3390/toxins12080519, PubMed 32823678

More publications

Get in touch

Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital – Radiumhospitalet P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Phone: +47-22781481 E mail: anette.weyergang@rr-research.no 

Twitter: @AWeyergang
LinkedIn

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)